<ѻýҕl>Make the Diagnosis: Increased Hair Loss and 'White Bulbs' -- What’s Up?ѻýҕl> A 55-year-old woman visited her doctor after noticing that the hair on her scalp was falling out at an increased rate over the last 3 months. Sep 14, 2022
<ѻýҕl>What Caused This Rapidly Enlarging Facial Abscess?ѻýҕl> Expansion over several weeks necessitated timely diagnosis and ruling out mimicking conditions Sep 13, 2022
<ѻýҕl>Inflammation Marker May Spot Atopic Dermatitis Risk Early in Childhoodѻýҕl> Elevated TARC at 2 months more than quadrupled the likelihood of moderate-severe AD at 2 years Sep 06, 2022
<ѻýҕl>Increased Health Spending When Private Equity Acquires Physician Practicesѻýҕl> Patient volume also increased, but whether patients are benefiting remains to be seen Sep 02, 2022
<ѻýҕl>Can COVID-19 Cause Hair Loss?ѻýҕl> Shedding may be induced by COVID-related stress, but hair will grow back, experts say Aug 12, 2022
<ѻýҕl>Study: Flares in Pustular Psoriasis Often Undertreatedѻýҕl> Drug firm hopes to bring new specific treatment to market Aug 10, 2022
<ѻýҕl>More Bad Safety News for Xeljanzѻýҕl> Yet another risk confirmed in postmarketing study Aug 04, 2022
<ѻýҕl>Asian Psoriasis Patients Get Less Time With Dermatologists, Study Suggestsѻýҕl> Cross-sectional study shows Asian patients have shortest face-to-face visits Aug 03, 2022
<ѻýҕl>What Caused Man's Saddle-Nose Deformity Years After Lymphoma Dx?ѻýҕl> Rare diagnosis points to need for thorough workup in patients with severe nasal congestion Aug 01, 2022
<ѻýҕl>Are Skin Lesion Analyzers Ready for Prime Time?ѻýҕl> FDA panel not fully on board to reclassify computer-aided melanoma detection devices Jul 30, 2022
<ѻýҕl>BDCA2-Targeting Antibody May Be Effective for Cutaneous Lupusѻýҕl> In small randomized trial, litifilimab shows superiority over placebo for skin disease activity Jul 27, 2022
<ѻýҕl>How Monkeypox Can Present Like Common STIsѻýҕl> Some cases involve just a single genital lesion, large multinational series shows Jul 26, 2022
<ѻýҕl>Sexual Dysfunction, Hair Loss Among Long COVID Symptomsѻýҕl> Wider range of post-COVID symptoms emerge than previously thought Jul 25, 2022
<ѻýҕl>A Monkeypox Momentѻýҕl> Let's use the lessons we learned from COVID-19 to battle this new disease threat Jul 25, 2022
<ѻýҕl>Dear Acne: You've Ruined My Life, I Hate Youѻýҕl> Personifying acne, scarring provides new insight into psychosocial burden of condition Jul 22, 2022
<ѻýҕl>Topical JAK Inhibitor OK'd for Repigmentation of Vitiligoѻýҕl> Significantly more patients achieved 75%, 90% improvement Jul 19, 2022
<ѻýҕl>Novel Nitric Oxide Gel Clears Kids' Molluscum Contagiosum Lesionsѻýҕl> Children may not need to "wait it out" for much longer, positive trial suggests Jul 13, 2022
<ѻýҕl>Make the Diagnosis: She’s Too Young for Lines on Her Faceѻýҕl> A 9-year-old girl was brought to the doctor by her mother after noticing a rash that had developed on the girl's face over the past week. Jul 13, 2022
<ѻýҕl>Chronic, Disfiguring Facial Rash With No Itching or Painѻýҕl> Female patient reports low quality of life after 10 years of treatments with no response Jul 11, 2022
<ѻýҕl>Odevixibat Scratches the Itch of Kids' Rare Liver Diseaseѻýҕl> Phase III trial showed reduced pruritus in progressive familial intrahepatic cholestasis Jul 08, 2022
<ѻýҕl>Which Biologics Stick Longest for Psoriasis?ѻýҕl> British data highlight factors affecting drug longevity Jul 06, 2022
<ѻýҕl>Does Sunlight Trigger Lupus?ѻýҕl> Analysis of data from major study suggests "yes," but falls short of clear conclusion Jun 22, 2022
<ѻýҕl>Health Equity, Gun Violence Prevention Among Priorities for AMA's New Presidentѻýҕl> Jack Resneck, Jr., MD, talks about running "the race we're in" Jun 15, 2022
<ѻýҕl>FDA Approves First Systemic Treatment for Alopecia Areataѻýҕl> Four to 10 times as many patients met hair-regrowth endpoint with JAK inhibitor versus placebo Jun 13, 2022
<ѻýҕl>Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Arthritisѻýҕl> Phase II results suggest drug could outperform existing agents Jun 03, 2022
<ѻýҕl>Why the Atypical Symptoms in the Latest Monkeypox Cases?ѻýҕl> Experts agree these cases are unusual, but not necessarily a concern for viral mutation May 27, 2022
<ѻýҕl>Oral Retinoid May Ease Painful Skin Reactions to Anticancer Therapyѻýҕl> Preliminary data on acitretin therapy are promising May 11, 2022
<ѻýҕl>In Lupus, 'Normal-Appearing' Skin Is Not Normalѻýҕl> Groundwork for inflammation laid before lesions develop Apr 27, 2022
<ѻýҕl>Testing for Th/To Antibodies May Help in Scleroderma Managementѻýҕl> Test identifies patients at high risk for pulmonary hypertension Apr 25, 2022
<ѻýҕl>FDA OKs New Topical for Inflammatory Rosaceaѻýҕl> Almost half of patients clear of lesions or nearly so with benzoyl peroxide 5% cream (Epsolay) Apr 25, 2022
<ѻýҕl>Smoker's Painless Skin Nodules Flag a Fatal Diagnosisѻýҕl> Skin metastasis was the first sign for the otherwise asymptomatic patient Apr 04, 2022
<ѻýҕl>First Topical Therapy for Facial Angiofibroma Nabs FDA Approvalѻýҕl> New alternative to dermabrasion, laser treatment, surgery Apr 04, 2022
<ѻýҕl>Chronic Spontaneous Urticaria Responds Quickly to BTK Inhibitorѻýҕl> AAD data also promising for therapies in psoriasis, pyoderma gangrenosum Mar 31, 2022
<ѻýҕl>Meta-Analysis of Atopic Dermatitis Drugs Favors Two JAK Inhibitorsѻýҕl> Small advantages for abrocitinib, upadacitinib, but data still accumulating for all the players Mar 30, 2022
<ѻýҕl>Toward More Uniform Methotrexate Dosing in Psoriasisѻýҕl> International expert group urges common standards Mar 30, 2022
<ѻýҕl>Jada Pinkett Smith's Alopeciaѻýҕl> The condition at the center of this year's Academy Awards drama Mar 29, 2022
<ѻýҕl>Significant Improvement in Vitiligo With JAK Inhibitor Therapyѻýҕl> Durable improvement in pigmentation with topical ruxolitinib, oral ritlecitinib Mar 29, 2022
<ѻýҕl>Targeted Antibody Provides Significant Relief From Itchy Nodular Conditionѻýҕl> Dupilumab reduces itch, lesion count in first phase III trial for prurigo nodularis Mar 28, 2022
<ѻýҕl>Dramatic, Durable Hair Growth With Oral JAK Inhibitorѻýҕl> Oral baricitinib superior to placebo at 36 weeks in BRAVE-AA1 and BRAVE-AA2 trials Mar 27, 2022
<ѻýҕl>Clinic-Based Hidradenitis Suppurativa Surgery Gets High Marks From Patientsѻýҕl> High satisfaction after three-fourths of procedures, despite frequent recurrences Mar 17, 2022